Strata Oncology Inc., a precision oncology company advancing molecular indications for cancer therapies based in Ann Arbor, announced the appointment of Sundu Brahmasandra as COO.
“We are excited to welcome Sundu Brahmasandra to the Strata Oncology family. As chief operating officer, Sundu will guide our journey to build and grow the company’s product development and delivery capabilities as we enter a new phase,” says Dan Rhodes, co-founder and CEO of Strata Oncology.
“Sundu’s experience building, leading and optimizing successful diagnostics companies will be invaluable to Strata Oncology as we continue growing and providing physicians and oncologists with information that can expand treatment options for patients with cancer.”
He brings more than 20 years of technical and operational leadership in the molecular diagnostics field to Strata Oncology, as well as experience developing biotechnology organizations.
“Having spent more than two decades in Ann Arbor’s biotech hub, I have the greatest admiration for what Strata Oncology has accomplished to date and am thrilled to be joining at such an exciting phase,” says Brahmasandra. “I look forward to working with this high-caliber team and helping the company navigate a period of high growth to achieve its full potential in helping physicians and patients on the right path to personalized cancer treatment.”